Smoking and the risk of type 2 diabetes

被引:222
作者
Maddatu, Judith
Anderson-Baucum, Emily
Evans-Molina, Carmella
机构
[1] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA
[2] Indiana Biosci Res Inst, Indianapolis, IN USA
[3] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA
[4] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA
[5] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA
[6] Roudebush VA Med Ctr, Indianapolis, IN USA
关键词
INDUCED INSULIN-RESISTANCE; SMOKELESS TOBACCO SNUS; CIGARETTE-SMOKING; ENVIRONMENTAL CHEMICALS; GLUCOSE-TOLERANCE; ARSENIC EXPOSURE; DNA METHYLATION; NICOTINE; CESSATION; MELLITUS;
D O I
10.1016/j.trsl.2017.02.004
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Despite accumulating evidence demonstrating strong epidemiologic and mechanistic associations between cigarette smoking, hyperglycemia, and the development of type 2 diabetes, tobacco abuse has not been uniformly recognized as a modifiable risk factor in diabetes prevention or screening strategies. In this review, we highlight population-based studies that have linked cigarette smoking with an increased risk of type 2 diabetes and summarize clinical and preclinical studies offering insight into mechanisms through which cigarette smoking and nicotine exposure impact body composition, insulin sensitivity, and pancreatic 13 cell function. Key questions for future studies are identified and strategies for smoking cessation as a means to decrease diabetes risk are discussed.
引用
收藏
页码:101 / 107
页数:7
相关论文
共 61 条
  • [1] [Anonymous], GLOB REP DIAB
  • [2] [Anonymous], 2014, Centers for Disease Control and Prevention
  • [3] Prioritizing Environmental Chemicals for Obesity and Diabetes Outcomes Research: A Screening Approach Using ToxCast™ High-Throughput Data
    Auerbach, Scott
    Filer, Dayne
    Reif, David
    Walker, Vickie
    Holloway, Alison C.
    Schlezinger, Jennifer
    Srinivasan, Supriya
    Svoboda, Daniel
    Judson, Richard
    Bucher, John R.
    Thayer, Kristina A.
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 2016, 124 (08) : 1141 - 1154
  • [4] Novel and Reversible Mechanisms of Smoking-Induced Insulin Resistance in Humans
    Bergman, Bryan C.
    Perreault, Leigh
    Hunerdosse, Devon
    Kerege, Anna
    Playdon, Mary
    Samek, Ali M.
    Eckel, Robert H.
    [J]. DIABETES, 2012, 61 (12) : 3156 - 3166
  • [5] Intramuscular Lipid Metabolism in the Insulin Resistance of Smoking
    Bergman, Bryan C.
    Perreault, Leigh
    Hunerdosse, Devon M.
    Koehler, Mary C.
    Samek, Ali M.
    Eckel, Robert H.
    [J]. DIABETES, 2009, 58 (10) : 2220 - 2227
  • [6] Smoke-related DNA methylation changes in the etiology of human disease
    Besingi, Welisane
    Johansson, Asa
    [J]. HUMAN MOLECULAR GENETICS, 2014, 23 (09) : 2290 - 2297
  • [7] Fetal and Neonatal Nicotine Exposure in Wistar Rats Causes Progressive Pancreatic Mitochondrial Damage and Beta Cell Dysfunction
    Bruin, Jennifer E.
    Petre, Maria A.
    Raha, Sandeep
    Morrison, Katherine M.
    Gerstein, Hertzel C.
    Holloway, Alison C.
    [J]. PLOS ONE, 2008, 3 (10):
  • [8] Nicotine receptor partial agonists for smoking cessation
    Cahill, Kate
    Lindson-Hawley, Nicola
    Thomas, Kyla H.
    Fanshawe, Thomas R.
    Lancaster, Tim
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (05):
  • [9] Cigarette smoking and fat distribution in 21,828 British men and women: A population-based study
    Canoy, D
    Wareham, N
    Luben, R
    Welch, A
    Bingham, S
    Day, N
    Khaw, KT
    [J]. OBESITY RESEARCH, 2005, 13 (08): : 1466 - 1475
  • [10] Smokeless tobacco (snus) is associated with an increased risk of type 2 diabetes: results from five pooled cohorts
    Carlsson, S.
    Andersson, T.
    Araghi, M.
    Galanti, R.
    Lager, A.
    Lundberg, M.
    Nilsson, P.
    Norberg, M.
    Pedersen, N. L.
    Trolle-Lagerros, Y.
    Magnusson, C.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2017, 281 (04) : 398 - 406